Does BRCA genetic testing treat ovarian cancer?

Treatment may involve surgery, medicines or other oncology care selected for the cancer's type, extent, previous response and the patient's health. BRCA testing supplies biological information that the team can use when considering certain targeted medicines; the sample collection and laboratory analysis do not destroy cancer cells.

Testing may look for an inherited BRCA variant in blood or saliva and for changes present only within tumour tissue. These findings answer different questions. An inherited finding may have implications for relatives, while a tumour finding may contribute to treatment planning even when it is not inherited.

A result needs specialist interpretation. A pathogenic variant, a negative finding and a variant of uncertain significance do not carry the same meaning. Treatment decisions also rely on pathology, scans, symptoms, prior therapy and overall fitness rather than on a BRCA result alone.

Ask whether the planned test uses blood, saliva, tumour tissue or a combination, and who will explain the report. Keep the complete laboratory result available for oncology and genetics appointments. If an inherited variant is confirmed, a genetic counsellor can help you decide how to inform relatives without assuming that they carry the same change.

Continue scheduled ovarian cancer treatment and monitoring while testing is arranged unless your oncology team changes the plan. A pending genetic result should not prompt you to start, stop or change anticancer medicine on your own.

Contact the oncology team promptly for worsening abdominal swelling, persistent vomiting, inability to keep fluids down, new shortness of breath, fever during systemic treatment, uncontrolled pain or a sudden decline in how you feel. The urgency comes from the symptom and current treatment, not from the BRCA result.

Seek emergency help for severe breathing difficulty, collapse, confusion, heavy bleeding or intense sudden pain. Use the treatment team's emergency number when one has been provided.

Consider asking whether the test examines inherited and tumour changes, how each possible result could alter treatment, whether genetic counselling is included, and what the plan will be if the sample is insufficient or the finding is uncertain.